A Randomised, Double-Blind, Repeat-Dose, Placebo-Controlled Phase IIa Proof of Concept Study to Investigate the Safety and Efficacy of Oral BBR-012 in Combination With Standard Medical Care in Diabetic Patients With Complicated Skin Ulceration on the Foot
Read time: 1 mins
Last updated:10th Mar 2011
To compare the rate of healing of DFUs, measured as percent reduction in wound area per week, after 28-days treatment with BBR-012 or placebo, in combination with standard medical therapy.
|Study start date||2011-03-10|